Lunac Therapeutics Limited
Private Limited Company · London
Creditors Voluntary Liquidation (CVL)United KingdomIncorporated 2018Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2024-05-31
IXBRL · 112 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2024-05-31
IXBRL · 112 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-06-01 to 2024-05-31
- Extraction status
- complete
- Numeric facts
- 54
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3600_11317849_20240531
- Source archive
- Accounts_Monthly_Data-February2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-05-31
IXBRL · 113 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2023-05-31
IXBRL · 113 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2022-06-01 to 2023-05-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 54
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_1766_11317849_20230531
- Source archive
- Accounts_Monthly_Data-February2024.zip
Accounts to 2019-04-30
IXBRL · 25 source facts · 2 selected values
Not assessedlegacy record
Accounts to 2019-04-30
IXBRL · 25 source facts · 2 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-18 to 2019-04-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 5
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0073_11317849_20190430
- Source archive
- Accounts_Monthly_Data-December2019.zip
Registered details
11317849- Status
- Liquidation
- Type
- Private Limited Company
- Incorporated
- 2018-04-18
- Jurisdiction
- —
- Registered office
- 29, CRAVEN STREET, LONDON, WC2N 5NT
Classification
1 SIC codes23105
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
2 matched grantsContinuity Award of Development of First-in class small molecule preclinical candidate anticoagulant targeting activated factor XII with minimal risk of bleeding -105439Lead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£249,917
awarded
Development of First-In Class Small Molecule Preclinical Candidate Anticoagulant Targeting Activated Factor XII with Minimal Risk of BleedingLeadInnovate UK · Collaborative R&D · 2019-09-01 – 2021-05-31 · with 2 other participants£1,610,865awarded
Development of First-In Class Small Molecule Preclinical Candidate Anticoagulant Targeting Activated Factor XII with Minimal Risk of BleedingLead
Innovate UK · Collaborative R&D · 2019-09-01 – 2021-05-31 · with 2 other participants
£1,610,865
awarded